Page 8 - Pharmaceutical Companies
Piramal Enterprises Q3 profit rises 11% to Rs 888 crore
The company had posted a net profit of Rs 799 crore for the same period last fiscal year
 "Piramal Enterprises Q3 profit rises 11% to Rs 888 crore")
Pharma company Venus Remedies joins AMR Industry Alliance
AMR Industry Alliance is the largest private-sector coalition working towards curbing AMR through a coordinated and multipronged response
 "Pharma company Venus Remedies joins AMR Industry Alliance")
Budget 2022: Pharma industry seeks enhanced funds for healthcare sector
The domestic pharmaceutical industry is expecting an increase in the overall fund allocation for the healthcare sector, focus on policies that encourage R&D activities and continuation of tax concessions on various drugs in the upcoming Union Budget. The industry is also seeking simplification of various processes in order to enhance ease of doing business for the private sector companies. "An increase in the budgetary allocation from the current 1.8 per cent of the GDP to 2.5-3 per cent, as envisaged in the National Health Policy 2017 along with a separate allocation for the bio-pharmaceutical sector R&D is imperative," Organisation of Pharmaceutical Producers of India (OPPI) President S Sridhar told PTI. The industry saw significant momentum over the past year, especially in ensuring access to COVID-19 vaccines and medicines and this year's Budget will be crucial to accelerate sectoral growth and access to innovative health solutions across various diseases and not COVID ...
 "Budget 2022: Pharma industry seeks enhanced funds for healthcare sector")
Australia's Woolworths makes $613 mln drugstore play, taking on Wesfarmers
The 11th-hour move from Woolworths sets the scene for a bid war between Australia's two largest retail companies
HC seeks Centre, Delhi govt's reply on plea for recruiting medicos
The Delhi High Court sought response of the Centre, the Delhi Government, and others on a plea seeking directions to fill the vacancies of doctors and paramedical staff in government-run hospitals
 "HC seeks Centre, Delhi govt's reply on plea for recruiting medicos")
Health ministry panel vetting requests by six cos to make Mucormycosis drug
Development come amid fast spread of disease in various states and shortage of drugs to treat it; Rajasthan has already declared an epidemic
 "Health ministry panel vetting requests by six cos to make Mucormycosis drug")
China halting flights to India could hurt pharma supplies, say companies
China supplies 60% to 70% of the raw materials used by India's drugmakers, according to an expert.
 "China halting flights to India could hurt pharma supplies, say companies")
India seeks investments from US companies in pharma, medical devices sector
India has reached out to top American pharma companies seeking investment in the country's pharmaceutical and medical devices sector
 "India seeks investments from US companies in pharma, medical devices sector")
India's Covid vaccination drive hangs in balance, and so does the world's
When the pandemic ends, it will be with the tremendous assistance of India's pharmaceutical industry.
 "India's Covid vaccination drive hangs in balance, and so does the world's")
Vardhman Health to invest Rs 100 crore in adult immunisation outreach
Company earned Rs 500 crore as revenue in FY21 and it plans to double it to over Rs 1,000 crore.
 "Vardhman Health to invest Rs 100 crore in adult immunisation outreach")
JB Chemicals: New launches, market share gains to drive growth
Key chronic segments have helped the JB Chemicals outperform the Indian pharma market.
 "JB Chemicals: New launches, market share gains to drive growth")
Asset monetisation, sales uptick in US key triggers for Glenmark Pharma
The India business is expected to post double digit growth in FY22
 "Asset monetisation, sales uptick in US key triggers for Glenmark Pharma")
Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton
Given the wider adoption of digital initiatives within the healthcare industry, Indegene plans to use the funds to accelerate its M&A (merger and acquisition) and global expansion plans
 "Indegene's valuation reaches $700 mn; raises $200 mn from Carlyle, Brighton")
Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%
Overall, the company saw decent growth in its product segments, led by cardio metabolic and vitamin-mineral-nutrients
 "Eris Lifesciences Q3 net up 42% to Rs 90 cr, total income rises by 14%")
Reform and incentives
Govt must seek to benefit manufacturing more broadly
 "Reform and incentives")
As domestic sales decline, drug makers focus on exports to sustain growth
During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis
 "As domestic sales decline, drug makers focus on exports to sustain growth")
GMM Pfaudler says ready to respond to charges on unusual trades during OFS
The stock continues to fall, and is down over 36 per cent since September 15
 "GMM Pfaudler says ready to respond to charges on unusual trades during OFS")
Export boost to help pharma sector come out unscathed from Covid-19: CRISIL
Exports and domestic formulations account for an almost equal share in the Rs 2.8-trillion domestic pharma sector, CRISIL said
Gilead nears deal to buy Immunomedics for more than $20 billion: Report
Discussions between Gilead and Immunomedics were initially centered around a partnership before shifting to a full-fledged takeover negotiation
Zydus Cadila gets approval from USFDA for muscle relaxant injection
Drugfirm Zydus Cadila has received final approval from the US health regulator to market Cisatracurium BesylateInjection, a muscle relaxant given before general anaesthesia
